Clinical Trials on Refractory Hematologic Malignancy
Total 21101 results
-
Epizyme, Inc.WithdrawnRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
St. Jude Children's Research HospitalRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyUnited States
-
Kai Lin Xu; Jun Nian ZhengiCarTAB BioMed Inc.UnknownRecurrent or Refractory B Cell MalignancyChina
-
Princess Maxima Center for Pediatric OncologyRecruitingRefractory Hematologic Malignancy | Relapsed Hematologic MalignancyNetherlands
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
Curis, Inc.RecruitingRelapsed Primary Central Nervous System Lymphoma | Refractory Hematologic Malignancy | Relapsed Hematologic Malignancy | Refractory Primary Central Nervous System LymphomaUnited States, Spain, France, Czechia, Israel, Italy, Poland
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI); Novartis PharmaceuticalsCompleted
-
SCRI Development Innovations, LLCBayerCompletedRefractory MalignancyUnited States
-
Shanxi Bethune HospitalRecruitingHematological MalignancyChina
-
Institut Paoli-CalmettesSanofiNot yet recruiting
-
The Affiliated People's Hospital of Ningbo UniversityRecruitingHematological MalignancyChina
-
University of Missouri-ColumbiaRecruiting
-
Zhejiang UniversityRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingRelapsed/Refractory Hematological MalignanciesChina
-
Henry Ford Health SystemRecruitingHematological MalignancyUnited States
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
University of CopenhagenZealand University HospitalEnrolling by invitationHematological MalignancyDenmark
-
Washington University School of MedicineBarnes-Jewish HospitalTerminatedHematological MalignancyUnited States
-
Institut Paoli-CalmettesCompletedHematological MalignancyFrance
-
Peking University People's HospitalSanofiRecruitingHematological MalignancyChina
-
M.D. Anderson Cancer CenterRecruiting
-
Beckman Coulter, Inc.Completed
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
-
University Hospital, Strasbourg, FranceUnknownHematological MalignancyFrance
-
Universitaire Ziekenhuizen KU LeuvenInstitutul Clinic FundeniCompletedHematological MalignancyBelgium, Romania
-
SCRI Development Innovations, LLCNovartisCompletedSolid Tumors | Refractory MalignancyUnited States
-
Onward TherapeuticsRecruitingSolid Tumor | Hematological MalignancyFrance
-
Antengene Therapeutics LimitedBristol-Myers SquibbRecruitingSolid Tumor | Hematological MalignancyAustralia
-
CASI Pharmaceuticals, Inc.CompletedRelapsed or Refractory Hematological MalignanciesCanada
-
Institute of Hematology & Blood Diseases HospitalJuventas Cell Therapy Ltd.AvailableRelapsed and Refractory Hematological MalignanciesChina
-
Shandong UniversityJuventas Cell Therapy Ltd.UnknownRelapsed or Refractory Hematological MalignanciesChina
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.LtdRecruiting
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHematological MalignancyUnited States
-
He HuangYake Biotechnology Ltd.RecruitingRelapsed and Refractory | Lymphoid Hematological MalignanciesChina
-
Shanghai Yuyao Biotech Co., Ltd.RecruitingAdvanced Solid Tumor | Hematological MalignancyChina
-
Inova Health Care ServicesRecruitingSolid Tumor | Hematological MalignancyUnited States
-
Institut BergoniéRecruitingSolid Tumor | Hematological MalignancyFrance
-
SCRI Development Innovations, LLCNovartisCompletedAdvanced Malignancies | Refractory MalignancyUnited States
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingHematologic MalignancyUnited States
-
Zhongnan HospitalRecruitingA Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic TumorsHematological Malignancy | Cancer-Related AnemiaChina
-
Constellation PharmaceuticalsCompletedSolid Tumor | Advanced Malignancies | Hematological MalignancySpain, United States, Georgia
-
Jules Bordet InstituteUniversité Libre de Bruxelles; Fondation Kisane; Les Amis de l'InstitutUnknownAdults | Hematological Malignancy | Oral Antineoplastic AgentsBelgium
-
Centre Hospitalier Universitaire de BesanconCompletedPalliative Care | Hematological Malignancy | Platelet TransfusionFrance
-
Assistance Publique Hopitaux De MarseilleRecruitingCancer and / or Hematological MalignancyFrance
-
Zhongnan HospitalRecruitingHematological Malignancy | CXCR4 | PET/CTChina
-
Munich Leukemia LaboratoryIllumina, Inc.RecruitingLeukemia | Rare Diseases | Refractory Lymphoma | Hematologic Malignancy | Refractory Leukemia | Unknown Primary TumorsGermany
-
Jens Rikardt AndersenCompleted
-
Massachusetts General HospitalTerminatedRefractory Lymphoma | Hematologic MalignancyUnited States
-
Andalusian Initiative for Advanced Therapies -...Iniciativa Andaluza en Terapias AvanzadasWithdrawnTransplant-Related Hematologic MalignancySpain